Compare ABCL & COUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ABCL | COUR |
|---|---|---|
| Founded | 2012 | 2012 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.6B |
| IPO Year | 2020 | 2021 |
| Metric | ABCL | COUR |
|---|---|---|
| Price | $5.97 | $5.37 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 15 |
| Target Price | $8.40 | ★ $10.53 |
| AVG Volume (30 Days) | ★ 7.5M | 7.3M |
| Earning Date | 05-11-2026 | 04-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 10.91 | ★ 39.22 |
| EPS | N/A | ★ N/A |
| Revenue | $75,128,000.00 | ★ $757,500,000.00 |
| Revenue This Year | N/A | $9.43 |
| Revenue Next Year | $21.85 | $6.40 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 160.56 | 9.04 |
| 52 Week Low | $2.75 | $5.00 |
| 52 Week High | $8.44 | $13.56 |
| Indicator | ABCL | COUR |
|---|---|---|
| Relative Strength Index (RSI) | 44.40 | 41.40 |
| Support Level | $5.23 | $5.11 |
| Resistance Level | $6.79 | $5.51 |
| Average True Range (ATR) | 0.61 | 0.24 |
| MACD | -0.23 | -0.04 |
| Stochastic Oscillator | 14.66 | 6.77 |
AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.
Coursera Inc is an online learning platform that connects learners, educators, and institutions with the goal of providing educational content that is affordable, accessible, and relevant. It combines content, data, and technology into a single, unified platform that is customizable and extensible to both individual learners and institutions. The company operates through two reporting segments: Consumer and Enterprise. The majority of revenue is generated from the Consumer segment. The consumer segment targets individual learners seeking to obtain hands-on learning, gain valuable job skills, receive professional-level certifications, and otherwise increase their knowledge to start or advance their careers.